CaseStudy

Client

Client Need

Solution Approach

Results

**Data has been sanitized and meant for Illustrative purposes only

Needed to evaluate the Asian market for the product acceptance of Nanotechnology based cardiac diagnostic platform, in which they were considering to invest for commercialization of the technology in Asian and other markets

Aagami involved a team of a senior and a junior Analyst to conduct primary and secondary research on cardiovascular disease and its diagnosis in Asia.

Parameters such as drawbacks of prevailing diagnosis methods & details of actual time taken by General practitioners , were studied, documented and analyzed.

Enumerated the benefits of using Nanoplasmonic tech – MI in cardiovascular, cancer & HIV.

Collated the key market trends in East & South Asia and highlighted the key findings in tabular & graphical presentation for quick analysis.

Prepared a concise report on the addressable and product acceptance for the new Technology in Cardiac Diagnostic market

Client found the report effective and helpful. The key market trends & insights provided, served as conclusive guidance to the client for finalizingfurther investment into the technology and preparing Market entry and Pricing strategy for Asian market.

Lifesciences Catalyst

Investors Controlled Innovative technology company